Contact and Follow-up Unit 

The Contact Unit leads health-related management, information, remote guidance, and follow-up activities. These activities are carried out both within the context of clinical care and as part of observational research and clinical trials. To ensure effectiveness, we utilize various technologies, such as 3CX software for managing inbound and outbound communications, Imedical for managing medical schedules, Sugar CRM for contact scheduling, and REDCap for data capture. These initiatives have significantly contributed to improving patient adherence to our comprehensive care program and to assembling a cohort of participants—committed to the study protocol—for clinical and observational studies, characterized by their demographic, virological, and serological profiles regarding infectious diseases.

Systems and Information Unit

The Systems and Information Unit comprises a professional team of systems engineers and technicians who support research projects by efficiently and effectively managing the technological resources required for data collection, storage, transfer, and quality assurance. They ensure regulatory and legal compliance while guaranteeing the confidentiality, integrity, and availability of information. The technological infrastructure implemented by the Systems and Information Unit enables the adaptation of multicenter projects, incorporating robust security measures to control access permissions.

Biological Sample Management Unit

The Sample Unit originated within our institution's Clinical Laboratory. It is responsible for managing biological samples based on standard operating procedures that ensure consistent handling and detailed traceability—covering everything from sample collection, preservation, centrifugation, and aliquoting to cold-chain storage—tailored to specific experimental requirements. This unit also encompasses the development of health service studies—grounded in scientific and ethical processes—that contribute to the detection of infectious agents (diagnosis) and the evaluation of potential treatments to protect public health, such as antiviral drugs, antibiotics, and vaccines.

Síguenos en Instagram @ipscdi